Q Pula Trading Management LP Gilead Sciences, Inc. Transaction History

Q Pula Trading Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $176,774 - $201,921	-2,969 Reduced 40.48%	4,366 $269,000
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $423,376 - $476,848	7,335 New	7,335 $453,000
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $473,299 - $537,203	-7,295 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $493,798 - $532,753	7,295 New	7,295 $510,000
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $528,705 - $577,685	-8,330 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $499,800 - $570,271	8,330 New	8,330 $538,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Q Pula Trading Management LP, based on Form 13F filings with the SEC.

Stay updated on Q Pula Trading Management LP with notifications on news.